Mark McGovern Net Worth & Insider Trades
Mark McGovern - Director, Esperion Therapeutics, Inc
What is Mark McGovern's Net Worth?
The current estimated net worth of Esperion Therapeutics, Inc's Director, Mark McGovern, is estimated to be about $95.96K . Mark McGovern owns about 5,000 units of Esperion Therapeutics, Inc common stock. In the last 6 years at Esperion Therapeutics, Inc, Mark McGovern has sold an estimated value of $0 worth.
What is Mark McGovern's Past Insider Trading?
Mark McGovern's largest purchase order was 5,000 units , worth over $50K on July 7, 2016. In total, Mark McGovern has made about 8 transactions over 6 years of their time at Esperion Therapeutics, Inc. Mark McGovern usually trades in May, with the busiest year in 2016.
MARK MCGOVERN
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What are Esperion Therapeutics, Inc's Past Insider Trades?
Esperion Therapeutics, Inc's most recent insider trade came on August 8, 2022 by Sheldon L Koenig who bought 8,606 units worth $49.95K . In the last 9 years, insiders at Esperion Therapeutics, Inc have sold an estimated value of $198.14M and bought an estimated value of $137.47M worth of shares. Insider trading is most common in May, with the busiest year in 2018. The most active traders at the company are Timothy Mayleben, President & CEO, Ag Biotech Bb, and Target Biotech V .
Esperion Therapeutics, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||